NO20052683D0 - Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents

Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Info

Publication number: NO20052683D0
Authority: NO; Norway
Prior art keywords: processes; preparation; new; pharmaceutical compositions; compositions containing
Prior art date: 2002-11-05

Application number

NO20052683A

Other languages

English (en)

Other versions

NO20052683L (no

Inventor

Sylvain Rault

Jean-Charles Lancelot

Pierre Renard

Daniel-Henri Caignard

Marina Kopp

Buno Pfeiffer

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-05

Filing date

2005-06-03

Publication date

2005-06-03

2005-06-03 Application filed by Servier Lab filed Critical Servier Lab

2005-06-03 Publication of NO20052683L publication Critical patent/NO20052683L/no

2005-06-03 Publication of NO20052683D0 publication Critical patent/NO20052683D0/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

NO20052683A 2002-11-05 2005-06-03 Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO20052683D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0213804A FR2846657B1 (fr)	2002-11-05	2002-11-05	Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2003/003274 WO2004043956A1 (fr)	2002-11-05	2003-11-04	Composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number	Publication Date
NO20052683L NO20052683L (no)	2005-06-03
NO20052683D0 true NO20052683D0 (no)	2005-06-03

Family

ID=32104442

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052683A NO20052683D0 (no)	2002-11-05	2005-06-03	Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (28)

Country	Link
US (1)	US7361662B2 (no)
EP (1)	EP1560826B1 (no)
JP (1)	JP2006512317A (no)
KR (1)	KR100717489B1 (no)
CN (1)	CN1330650C (no)
AR (1)	AR041883A1 (no)
AT (1)	ATE323092T1 (no)
AU (1)	AU2003292320B2 (no)
BR (1)	BR0315801A (no)
CA (1)	CA2503995A1 (no)
CY (1)	CY1105047T1 (no)
DE (1)	DE60304599T2 (no)
DK (1)	DK1560826T3 (no)
EA (1)	EA009043B1 (no)
ES (1)	ES2261978T3 (no)
FR (1)	FR2846657B1 (no)
GE (1)	GEP20084376B (no)
HK (1)	HK1081965A1 (no)
MA (1)	MA27410A1 (no)
MX (1)	MXPA05004789A (no)
MY (1)	MY140164A (no)
NO (1)	NO20052683D0 (no)
NZ (1)	NZ539598A (no)
PL (1)	PL376399A1 (no)
PT (1)	PT1560826E (no)
UA (1)	UA80578C2 (no)
WO (1)	WO2004043956A1 (no)
ZA (1)	ZA200503233B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2007303846B2 (en) *	2006-10-04	2011-03-10	Pfizer Products Inc.	Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor antagonists
CN101531638B (zh) *	2008-03-13	2011-12-28	中国科学院广州生物医药与健康研究院	用作***相关受体调节剂的化合物及其应用
CN101619063B (zh) *	2009-06-02	2011-08-10	华中师范大学	具有抗肿瘤活性的3,7,8-多取代吡啶并[4,3-d]嘧啶衍生物及制备
US8981087B2 (en)	2009-07-29	2015-03-17	Karus Therapeutics Limited	Benzo [E] [1,3] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors
PL2467387T3 (pl)	2009-08-20	2015-08-31	Karus Therapeutics Ltd	Tricykliczne związki heterocykliczne jako inhibitory kinazy 3-fosfoinozytydu
GB201204125D0 (en)	2012-03-08	2012-04-25	Karus Therapeutics Ltd	Compounds
EA030253B1 (ru)	2012-09-28	2018-07-31	Кэнсэр Ресерч Текнолоджи Лимитед	Азахиназолиновые ингибиторы атипичной протеинкиназы c
GB201402431D0 (en)	2014-02-12	2014-03-26	Karus Therapeutics Ltd	Compounds
WO2016068580A2 (en)	2014-10-29	2016-05-06	Dong-A Socio Holdings Co., Ltd.	Novel pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (kdms)
GB201514751D0 (en)	2015-08-19	2015-09-30	Karus Therapeutics Ltd	Compounds
GB201514754D0 (en)	2015-08-19	2015-09-30	Karus Therapeutics Ltd	Compounds
GB201514760D0 (en)	2015-08-19	2015-09-30	Karus Therapeutics Ltd	Compounds and method of use
GB201514758D0 (en)	2015-08-19	2015-09-30	Karus Therapeutics Ltd	Formulation
US20170057955A1 (en) *	2015-08-26	2017-03-02	Dong-A Socio Holdings Co., Ltd.	Pyridopyrimidinone Compounds for Modulating the Catalytic Activity of Histone Lysine Demethylases (KDMs)
CN105616420A (zh) *	2016-01-16	2016-06-01	赵国良	一种降血脂的药物组合物
IL277071B1 (en)	2018-03-08	2024-03-01	Incyte Corp	Aminopyrizine diol compounds as PI3K–y inhibitors
US11046658B2 (en)	2018-07-02	2021-06-29	Incyte Corporation	Aminopyrazine derivatives as PI3K-γ inhibitors
WO2021102288A1 (en) *	2019-11-22	2021-05-27	Senda Biosciences, Inc.	Pyridopyrimidinone derivatives as ahr antagonists
WO2024008722A2 (en) *	2022-07-04	2024-01-11	Muna Therapeutics Aps	Trem2 modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6348310B1 (en) *	1994-03-04	2002-02-19	Promega Corporation	Quantitation of individual protein kinase activity
US6060477A (en) *	1995-06-07	2000-05-09	Cell Pathways, Inc.	Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives
ZA9756B (en) *	1996-01-16	1997-07-17	Warner Lambert Co	Process for preparing 4,6-disubstituted pyrido[3,4-d]-pyrimidines
HRP970371A2 (en) *	1996-07-13	1998-08-31	Kathryn Jane Smith	Heterocyclic compounds
KR20000029843A (ko) *	1996-08-06	2000-05-25	디. 제이. 우드;스피겔 알렌 제이	치환된피리도-또는피리미도-함유6,6-또는6,7-비시클릭유도체
US6962922B2 (en) *	2001-10-12	2005-11-08	Warner-Lambert Company Llc	Alkynylated quinazoline compounds
AUPS019702A0 (en) *	2002-01-29	2002-02-21	Fujisawa Pharmaceutical Co., Ltd.	Condensed heterocyclic compounds

2002
- 2002-11-05 FR FR0213804A patent/FR2846657B1/fr not_active Expired - Fee Related
2003
- 2003-04-11 UA UAA200505315A patent/UA80578C2/uk unknown
- 2003-10-09 MY MYPI20033854A patent/MY140164A/en unknown
- 2003-11-04 JP JP2004550726A patent/JP2006512317A/ja active Pending
- 2003-11-04 AR ARP030104026A patent/AR041883A1/es unknown
- 2003-11-04 US US10/533,697 patent/US7361662B2/en not_active Expired - Fee Related
- 2003-11-04 CA CA002503995A patent/CA2503995A1/fr not_active Abandoned
- 2003-11-04 WO PCT/FR2003/003274 patent/WO2004043956A1/fr active IP Right Grant
- 2003-11-04 EA EA200500690A patent/EA009043B1/ru not_active IP Right Cessation
- 2003-11-04 BR BR0315801-2A patent/BR0315801A/pt not_active IP Right Cessation
- 2003-11-04 MX MXPA05004789A patent/MXPA05004789A/es active IP Right Grant
- 2003-11-04 ES ES03767886T patent/ES2261978T3/es not_active Expired - Lifetime
- 2003-11-04 AU AU2003292320A patent/AU2003292320B2/en not_active Expired - Fee Related
- 2003-11-04 KR KR1020057007994A patent/KR100717489B1/ko not_active IP Right Cessation
- 2003-11-04 DK DK03767886T patent/DK1560826T3/da active
- 2003-11-04 EP EP03767886A patent/EP1560826B1/fr not_active Expired - Lifetime
- 2003-11-04 PL PL03376399A patent/PL376399A1/xx not_active Application Discontinuation
- 2003-11-04 GE GEAP20038824A patent/GEP20084376B/en unknown
- 2003-11-04 CN CNB2003801027139A patent/CN1330650C/zh not_active Expired - Fee Related
- 2003-11-04 PT PT03767886T patent/PT1560826E/pt unknown
- 2003-11-04 NZ NZ539598A patent/NZ539598A/en unknown
- 2003-11-04 DE DE60304599T patent/DE60304599T2/de not_active Expired - Fee Related
- 2003-11-04 AT AT03767886T patent/ATE323092T1/de not_active IP Right Cessation
2005
- 2005-04-19 MA MA28232A patent/MA27410A1/fr unknown
- 2005-04-21 ZA ZA200503233A patent/ZA200503233B/en unknown
- 2005-06-03 NO NO20052683A patent/NO20052683D0/no not_active Application Discontinuation
2006
- 2006-02-22 HK HK06102331A patent/HK1081965A1/xx not_active IP Right Cessation
- 2006-06-08 CY CY20061100767T patent/CY1105047T1/el unknown

Also Published As

Publication number	Publication date
EP1560826A1 (fr)	2005-08-10
KR20050087792A (ko)	2005-08-31
EA200500690A1 (ru)	2005-10-27
MA27410A1 (fr)	2005-06-01
US7361662B2 (en)	2008-04-22
CN1711260A (zh)	2005-12-21
EA009043B1 (ru)	2007-10-26
FR2846657A1 (fr)	2004-05-07
ATE323092T1 (de)	2006-04-15
PT1560826E (pt)	2006-07-31
CY1105047T1 (el)	2009-11-04
EP1560826B1 (fr)	2006-04-12
NZ539598A (en)	2006-11-30
HK1081965A1 (en)	2006-05-26
DK1560826T3 (da)	2006-08-14
UA80578C2 (en)	2007-10-10
US20050288311A1 (en)	2005-12-29
BR0315801A (pt)	2005-09-20
WO2004043956A8 (fr)	2005-06-09
KR100717489B1 (ko)	2007-05-14
ZA200503233B (en)	2006-06-28
PL376399A1 (en)	2005-12-27
DE60304599D1 (de)	2006-05-24
WO2004043956A1 (fr)	2004-05-27
NO20052683L (no)	2005-06-03
AR041883A1 (es)	2005-06-01
MXPA05004789A (es)	2005-07-22
ES2261978T3 (es)	2006-11-16
FR2846657B1 (fr)	2004-12-24
AU2003292320B2 (en)	2009-03-12
JP2006512317A (ja)	2006-04-13
GEP20084376B (en)	2008-05-27
MY140164A (en)	2009-11-30
AU2003292320A1 (en)	2004-06-03
CN1330650C (zh)	2007-08-08
CA2503995A1 (fr)	2004-05-27
DE60304599T2 (de)	2007-05-16

Similar Documents

Publication	Publication Date	Title
NO20052683D0 (no)	2005-06-03	Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20054329D0 (no)	2005-09-20	Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike
NO20054876D0 (no)	2005-10-21	Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
NO20042805L (no)	2004-07-02	Nye forbindelser og deres anvendelse innen medisin, fremgangsmate for deres fremstilling og farmaoytiske sammensetninger som inneholder dem
NO20023643L (no)	2002-09-30	Forbindelser som har antitumoraktivitet, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholderdem
NO20055167D0 (no)	2005-11-03	Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20055835D0 (no)	2005-12-08	Cykliske aminderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20010522D0 (no)	2001-01-30	Nye piperidin-4-sulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20052414L (no)	2005-11-21	Nye pyrrolidin- og tiazolidinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20043188L (no)	2005-01-31	Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20052598D0 (no)	2005-05-30	Nye 2,3-dihydro-4(1H)-pyridonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem.
NO20010305L (no)	2001-07-20	Nye benzensulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20031219D0 (no)	2003-03-17	Nye forbindelser avledet fra kinazolin, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20031643D0 (no)	2003-04-10	Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20034614L (no)	2004-04-19	Nye [3,4-a:3,4-c]karbazolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20041313L (no)	2004-10-11	Nye isokinolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20042978L (no)	2004-07-14	Nye benzotiazin- og benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20050391D0 (no)	2005-01-25	Nye fluorinerte benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20021330D0 (no)	2002-03-18	Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20043910L (no)	2004-09-20	Nye aminosyreforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20042422L (no)	2004-12-14	Nye benzotiazin- og benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20052330D0 (no)	2005-05-12	Nye substituerte [1,4]benzodioksino[2,3]isoindolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20043880L (no)	2005-03-17	Nye benzoindolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20021198L (no)	2002-09-13	Nye isoindoloindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20035215L (no)	2003-11-24	Tricykliske dihydrokinolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Legal Events

Date	Code	Title	Description
2010-06-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application